Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Zomedica Corp. Common Shares (NY:ZOM)

0.0973 UNCHANGED
Last Price Updated: 8:00 PM EST, Mar 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Zomedica Corp. Common Shares

< Previous 1 2 3 4 5 6 Next >
News headline image
There’s a Reason to Consider Buying Zomedica, and It’s a Real Shocker ↗
ZOM stock is far from a market darling, but an underreported acquisition could breathe new life into Zomedia's struggling business. 
Via InvestorPlace
News headline image
Zomedica Remains a Speculative Play in the Veterinary Field ↗
The dismal run of ZOM Stock likely to continue for the foreseeable future, until it meaningfully improves its top and bottom-line numbers. 
Via InvestorPlace
News headline image
Analysis: Robinhood's 2 Top Losers From Its 'Most Popular' Watchlist ↗
Centro Electric Group Ltd. (NASDAQ:NAKD) and Zomed... 
Via Benzinga
News headline image
Top 10 Meme Stocks of 2021 and How They’ll Fare in 2022 ↗
Retail investors continue to price meme stocks higher. So it's time to look at 10 meme stocks and consider how they'll fare in 2022. 
Via InvestorPlace
News headline image
7 Tempting Stocks to Avoid Until These Key Issues Get Ironed Out ↗
Someday, the challenges and hurdles affecting them could clear up. But for now, consider this group of seven popular plays stocks to avoid. 
Via InvestorPlace
Topics Economy
News headline image
Zomedica Stock Soars After $71M Pulse Veterinary Acquisition ↗
Zomedica Corp (NYSE:ZOM) has acquired the 
Via Benzinga
News headline image
Penny Stocks to Watch: What’s Going on With ZOM, DARE, PSFE, EFOI and AUUD Today? ↗
Penny stocks are still a hot topic among retail traders and we're covering some of the top ones to watch Wednesday that are on the move. 
Via InvestorPlace
News headline image
22 Stocks Moving in Wednesday's Pre-Market Session ↗
Gainers Daré Bioscience, Inc. (NASDAQ: DARE) rose 45.2% to $3.08 in pre-market trading after the company reported the FDA approval of XACIATO Vaginal Gel as a treatment... 
Via Benzinga
News headline image
2 Big Stock Bets That Are Insiders Are Buying Now ↗
Reddit users picked their favorite biotech stocks, and all of them have fallen this year. The insiders have a different buying strategy. 
Via InvestorPlace
News headline image
Zomedica Stock Looks Tempting Here, But There’s Likely More Downside ↗
Early in 2021, ZOM stock was part of the meme stock trade, but recent catalysts suggest it may be moving toward investment territory. 
Via InvestorPlace
News headline image
Zomedica Is Languishing Today, but Keep an Eye on This Risky Play ↗
It's a risky play no doubt, but ZOM stock stands to get out of its current rut as a key temporary issue subsides. 
Via InvestorPlace
News headline image
7 Penny Stocks That Could Have an Explosive Year-End ↗
While meme trends are on the wane, these seven penny stocks still stand to make turbocharged moves higher in the short-term. 
Via InvestorPlace
News headline image
Pet Stocks Alert: What Is Going on With PETZ and ZOM Stocks Today? ↗
Speculative pet stocks TDH Holdings and Zomedica are jumping higher in morning trading but investors should be skeptical of the moves. 
Via InvestorPlace
News headline image
6 of the Hottest Stocks to Pick Up for Less Than $1 ↗
These penny stocks are trading for under a dollar, but could change that in the coming months with their strong fundamentals. 
Via InvestorPlace
News headline image
Stay Away From Zomedica for These 3 Key Reasons ↗
ZOM stock had its best days in early 2021, but now its weak financial performance fully justifies its price weakness. 
Via InvestorPlace
News headline image
Zomedica Management Finally Delivers Some Good News ↗
Zomedica's acquisition is precisely what was needed to get ZOM stock out of its lethargy. Long-term, it could be a game-changer. Here’s why. 
Via InvestorPlace
News headline image
Zomedica Stock Will Need More Than a Change in Management to Bounce Back ↗
If the economy falters, past precedent looms ominously for ZOM stock. 
Via InvestorPlace
Topics Economy
News headline image
New CEO and Acquisition Could Breathe New Life Into Zomedica ↗
A turnaround in ZOM stock may happen sooner rather than later as Zomedica undergoes an executive-level change and builds out its business. 
Via InvestorPlace
News headline image
Zomedica Has Potential, but It’s Far Too Expensive for Now ↗
ZOM stock can be a pet care industry leader, but it needs to make significant improvements before becoming a solid long-term play. 
Via InvestorPlace
News headline image
The Challenges for Zomedica Continue, But It Still Has Huge Potential ↗
Patience is key with this name, but as it still stands to grab a piece of a multi-billion dollar market, ZOM stock remains worth the risk. 
Via InvestorPlace
News headline image
3 Hot Penny Stocks: Why ZOM, AEZS and PROG Are Seeing Big Gains Today ↗
A few hot penny stocks are seeing major movement on Friday as shares ride higher and we've got all the details traders need. 
Via InvestorPlace
News headline image
ZOM Stock: There’s a $71 Million Reason Zomedica Is Gaining Today ↗
ZOM stock is up big today on news of a big merger. The company is acquiring proven vet tech outfit PulseVet in an all-cash deal. 
Via InvestorPlace
News headline image
Why Zomedica Shares Are Soaring Today ↗
Zomedica Corp (AMEX:ZOM) is trading significantly higher Friday after the company announced the purchase of Pulse Veterinary Technologies for $70.9 million in cash and stock... 
Via Benzinga
News headline image
With the Crickets Chirping at Zomedica HQ, Why Buy the Stock? ↗
The only word out of Zomedica in September was its announcement of a new director. That’s not the news ZOM stock needs right now. 
Via InvestorPlace
News headline image
Even 53 Cents Is Too Much for Zomedica Stock Right Now ↗
At one point, investors loved Zomedica. But until its plans come to fruition, ZOM stock doesn't look like much of a deal. 
Via InvestorPlace
News headline image
If at First Zomedica Doesn’t Succeed, It Tries, Tries Again ↗
The launch of the Truforma diagnostic platform didn't go perfectly for Zomedica, but holders of ZOM stock still have reason for optimism. 
Via InvestorPlace
News headline image
Is Zomedica Stock Worth the Risk? Unfortunately It’s Complicated ↗
Zomedica started selling its TRUFORMA vet diagnostic system in March, but ZOM stock won’t see upside until supplier assay issues are resolved. 
Via InvestorPlace
Topics Supply Chain
News headline image
Why Economic Pressure May Build Against Zomedica ↗
Although ZOM stock banks superficially on millennials’ love for pets, brewing economic pressures may undo this catalyst. 
Via InvestorPlace
News headline image
Zomedica Continues to Execute Poorly ↗
It's been 3.5 months since Zomedica launched Truforma. Unfortunately, due to its poor execution, ZOM stock continues to suffer. 
Via InvestorPlace
News headline image
Zomedica’s Business Model Is Good, But It’s Still Overpriced ↗
Giving away razors and charging for the blades is often a good idea, but ZOM stock still isn't a good value until it drops closer to 40 cents. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.